论文部分内容阅读
目的比较经尿道前列腺等离子电切剜除术(TUPKEP)与经尿道前列腺电切术(TURP)治疗良性前列腺增生(BPH)的安全性及临床疗效。方法回顾性分析2008年1月至2010年3月在本院TUPKEP和TURP治疗的良性前列腺增生的病例资料116例,TUPKEP组46例,TURP组70例。通过比较手术时间、术中出血量、前列腺切除质量、术后膀胱冲洗时间和并发症发生率评价两种手术方式的安全性,通过比较术后3个月国际前列腺症状评分(I-PSS)、生活质量评分(QOL)、最大尿流率(Qmax)及残余尿量(PRV)等评价两种手术方式的疗效。结果 TUPKEP组手术时间、术中出血量、术后冲洗时间和并发症的发生率明显低于TURP组,前列腺切除质量高于TURP组,差异具有统计学意义(P<0.05);术后3个月两组中I-PSS、QOL、Qmax、PRV较术前都明显改善,但是两组间差异无统计学意义(P>0.05)。结论 TUPKEP与TURP治疗BPH的疗效相近,但TUP-KEP平均手术时间短、术中出血量少、并发症发生率低,手术安全性更高,具有良好的应用前景。
Objective To compare the safety and clinical efficacy of transurethral resection of prostatectomy (TUPKEP) and transurethral resection of prostate (TURP) for benign prostatic hyperplasia (BPH). Methods A retrospective analysis of 116 cases of benign prostatic hyperplasia treated with TUPKEP and TURP in our hospital from January 2008 to March 2010 was performed. There were 46 cases in TUPKEP group and 70 cases in TURP group. The safety of the two surgical methods was evaluated by comparing the operation time, blood loss, the quality of resection of prostate, the time of postoperative bladder irrigation and the incidence of complications. By comparing the International Prostate Symptom Score (I-PSS) at 3 months postoperatively, Quality of life score (QOL), maximum flow rate (Qmax) and residual urine volume (PRV) and other evaluation of the efficacy of the two surgical methods. Results The operative time, intraoperative blood loss, postoperative flushing time and complications were significantly lower in TUPKEP group than those in TURP group (P <0.05). The quality of prostatectomy was significantly higher than that in TURP group (P <0.05) The I-PSS, QOL, Qmax and PRV in the two groups were significantly improved compared with those before operation, but there was no significant difference between the two groups (P> 0.05). Conclusions TUPKEP and TURP are effective in treating BPH. However, TUP-KEP has the advantages of short average operation time, less intraoperative blood loss, lower complication rate and higher operative safety, and has good application prospect.